000627.SZ
Price:
$1.58
Market Cap:
$7.75B
Hubei Biocause Pharmaceutical Co., Ltd. primarily provides life and motor insurance products in China. The company also engages in the pharmaceutical, chemical, and new energy fuel businesses. In addition, it is involved in the contract research and production of APIs, intermediates, and formulations, including tablets, granules, capsules, etc.; and provision of chemicals comprising dimethyl ether gas and a-chloropropionyl chloride. The company exports its products to the United States, the European Union, and internationally. Hubei Biocause Pharmaceutical Co., Ltd. is based in Jingmen, China.
Industry
Insurance - Life
IPO Date
1996-11-12
Stock Exchange
SHZ
Ticker
000627.SZ
According to Hubei Biocause Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 16.97B. This represents a change of -0.67% compared to the average of 17.09B of the last 4 quarters.
The mean historical Enterprise Value of Hubei Biocause Pharmaceutical Co., Ltd. over the last ten years is 15.03B. The current 16.97B Enterprise Value has changed 11.19% with respect to the historical average. Over the past ten years (40 quarters), 000627.SZ's Enterprise Value was at its highest in in the September 2018 quarter at 35.63B. The Enterprise Value was at its lowest in in the January 2023 quarter at -3758186907.65.
Average
15.03B
Median
14.45B
Minimum
1.79B
Maximum
32.41B
Discovering the peaks and valleys of Hubei Biocause Pharmaceutical Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 586.87%
Maximum Annual Enterprise Value = 32.41B
Minimum Annual Increase = -93.60%
Minimum Annual Enterprise Value = 1.79B
| Year | Enterprise Value | Change |
|---|---|---|
| 2023 | 11.35B | -34.64% |
| 2022 | 17.37B | 586.87% |
| 2021 | 2.53B | 41.48% |
| 2020 | 1.79B | -93.60% |
| 2019 | 27.92B | 101.07% |
| 2018 | 13.88B | -57.16% |
| 2017 | 32.41B | 51.55% |
| 2016 | 21.39B | 42.36% |
| 2015 | 15.02B | 125.21% |
| 2014 | 6.67B | 71.53% |
The current Enterprise Value of Hubei Biocause Pharmaceutical Co., Ltd. (000627.SZ) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
10.42B
5-year avg
12.19B
10-year avg
15.03B
Hubei Biocause Pharmaceutical Co., Ltd.’s Enterprise Value is less than Changjiang Securities Company Limited (117.91B), less than Jilin Aodong Pharmaceutical Group Co., Ltd. (23.50B), less than Guoyuan Securities Company Limited (125.59B), less than Tongling Nonferrous Metals Group Co.,Ltd. (92.54B), less than Hbis Company Limited (174.85B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 117.91B | $44.68B | |
| 23.50B | $22.46B | |
| 125.59B | $36.04B | |
| 92.54B | $70.81B | |
| 174.85B | $23.16B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hubei Biocause Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Hubei Biocause Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Hubei Biocause Pharmaceutical Co., Ltd.'s Enterprise Value?
What is the highest Enterprise Value for Hubei Biocause Pharmaceutical Co., Ltd. (000627.SZ)?
What is the 3-year average Enterprise Value for Hubei Biocause Pharmaceutical Co., Ltd. (000627.SZ)?
What is the 5-year average Enterprise Value for Hubei Biocause Pharmaceutical Co., Ltd. (000627.SZ)?
How does the current Enterprise Value for Hubei Biocause Pharmaceutical Co., Ltd. (000627.SZ) compare to its historical average?